ndst1-dependent heparan sulfate regulates bmp signaling and internalization in lung ... ·...
TRANSCRIPT
1145Research Article
IntroductionLung epithelium and mesenchyme generate essential secreted
proteins for each other and thus coordinate lung embryonic
morphogenesis. Multiple factors, including bone morphogenetic
proteins (BMPs), fibroblast growth factors (FGFs) and hedgehog
are reportedly involved in lung formation. Inhibition of BMP
signaling with the BMP antagonist, noggin (NOGG) or dominant-
negative BMP receptor (dnAlk6) alters expression of FOXJ1,
uteroglobin (UTER/CC10) and pulmonary surfactant-associatedprotein C (PSPC/SFTPC) and causes a severe reduction in distal
lung epithelial cell types and an increase in proximal cell types
(Weaver et al., 1999). Ectopic expression of gremlin (GREM1),
another antagonist of BMP, results in disruption of the proximal-
distal pattern in embryonic lung (Lu et al., 2001). In addition,
deletion of BMPR1a or BMP4 in mouse lung epithelium leads to
reduction in number of type II pneumocyte and a decrease in
epithelial proliferation (Eblaghie et al., 2006). Misexpression of
BMP4 also causes a decrease of type II cells and inhibition of
epithelial proliferation, along with cell death in the mesenchyme
during lung development (Bellusci et al., 1996). Abnormal septa
in alveolar were observed in mice with deletions of FGFR3 and
FGFR4 (Weinstein et al., 1998). Overexpression of Sonic hedgehog
leads to an abundance of mesenchyme and loss of typical alveoli
(Bellusci et al., 1997). Additional signals such as EGF, Wnt and
TGFβ are also important in lung development.
A number of signaling pathways including BMP, FGF, hedgehog
and Wnt depend on heparan sulfate proteoglycans (HSPGs) (Hacker
et al., 2005; Lin, 2004). HSPGs are macromolecules composed of
heparan sulfate glycosaminoglycan (GAG) side chains covalently
bound to core proteins. Biosynthesis of heparan sulfate (HS) is
initiated from a chain composed of repeated D-glucuronic acid
(GlcUA) N-acetyl-D-glucosamine (GlcNAc) residues. The
glucosaminoglycan chains first undergo N-deacetylation and N-
sulfation of selected GlcNAc residues by GlcNAc N-deacetylase/N-
sulfotransferase (NDST) (Lindahl et al., 1998; Salmivirta et al.,
1996). The subsequent modifications, such as C-5 epimerization of
GlcA to iduronic acid (IdoA) and O-sulfation at various positions,
are dependent on the prior N-sulfation of GlcN units created by
NDST (Esko and Selleck, 2002; Lindahl et al., 1998). NDST has
a key role in the modification of the HS polysaccharide chain.
Genes encoding four known NDST isozymes, Ndst1-Ndst4, have
been identified in mammals (Aikawa and Esko, 1999; Aikawa et
al., 2001; Eriksson et al., 1994; Hashimoto et al., 1992; Kusche-
Gullberg et al., 1998). Ndst1 and Ndst2 are expressed ubiquitously
in both embryonic and adult mice, whereas Ndst3 and Ndst4 are
mostly expressed during embryonic development (Ford-Perriss et
al., 2002; Grobe et al., 2002; Miettinen et al., 1997; Yabe et al.,
2005). Mice lacking Ndst2 have abnormal mast cells without
properly sulphated heparin and mast-cell proteases (Forsberg et al.,
1999; Humphries et al., 1999), and those lacking Ndst3 have no
obvious phenotype (Grobe et al., 2002). However, disruption of Ndst1results in severe malformations in lung, brain, cranial facial, lens,
vascular, skeletal, and lacrimal gland development (Abramsson et
al., 2007; Fan et al., 2000; Grobe et al., 2005; Hu et al., 2007; Pan
et al., 2008; Pan et al., 2006; Ringvall et al., 2000). Thus, NDST1
is an essential NDST isozyme in mouse embryonic development.
Previously we reported that Ndst1 mutant mice developed
atelectasis and respiratory distress and died shortly after birth (Fan
Heparan sulfate proteoglycans (HSPGs) are required for various
signaling pathways, one of which is the bone morphogenetic
protein (BMP) signaling pathway. N-deacetylase/N-
sulfotransferase-1 (NDST1) participates in synthesizing heparan
sulfate (HS) chains of HSPGs, and is involved in bone and lung
development. Here, we report that in spite of the redundant
expression of Ndst2, Ndst3 and Ndst4 genes, Ndst1–/– mice
display defective differentiation of lung cells and increased cell
proliferation. Loss of Ndst1 in the lung enhances downstream
BMP signaling in vivo. Noggin, which is an antagonist of BMP,
can rescue the Ndst1–/– lung morphogenetic defects in explant
cultures. Further studies in vitro indicated that loss of Ndst1significantly impairs BMP internalization by decreasing BMP
binding to endogenous HS. Exogenous heparin can rescue both
the BMP signaling and BMP internalization abnormalities in
Ndst1–/– lung. Thus, we propose that HS regulates BMP signaling
by controlling the balance between BMP binding to HS, and
that BMP receptors and NDST1-dependent modification are
essential for this process. The results suggest that NDST1-
dependent HS is essential for proper functioning of BMP in
embryonic lung development.
Supplementary material available online at
http://jcs.biologists.org/cgi/content/full/122/8/1145/DC1
Key words: NDST1, BMP signaling, Lung development
Summary
NDST1-dependent heparan sulfate regulates BMPsignaling and internalization in lung developmentZhonghua Hu1,*, Chaochen Wang1,*, Ying Xiao2, Nengyin Sheng3, Yibin Chen1, Ye Xu1, Liang Zhang1,Wei Mo1, Naihe Jing3 and Gengxi Hu1,‡
1State Key Laboratory of Molecular Biology, 2State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica and 3Laboratory ofMolecular Cell Biology, Key Laboratory of Stem Cell Biology, Institute of Biochemistry and Cell Biology, Shanghai Institute for Biological Sciences,Chinese Academy of Sciences, 200031 Shanghai, China*These authors contributed equally to this work‡Author for correspondence (e-mail: [email protected])
Accepted 2 December 2008Journal of Cell Science 122, 1145-1154 Published by The Company of Biologists 2009doi:10.1242/jcs.034736
Jour
nal o
f Cel
l Sci
ence
1146
et al., 2000). However, the detailed developmental defects and the
underlying mechanisms of NDST1-depedent HS modulation of
signaling pathways remain unclear. Here, we report that BMP
signaling is affected in Ndst1 mutant lung, which could be one of
the causes of defective lung development.
ResultsAbnormal lung morphogenesis in Ndst1 mutantsMouse lung arises from the laryngotracheal groove at 9.5 days post
coitum (d.p.c.). Terminal sacs and vascularization develop in the
period of 16.5-17.5 d.p.c. After 17.5 d.p.c., the number of terminal
sacs and vascularization increase and type I and type II cells
differentiate (Warburton et al., 2000). Previous studies have
demonstrated that Ndst1-null mice develop pulmonary hypoplasia
and neonatal respiratory distress (Fan et al., 2000; Ringvall et al.,
2000). To further characterize the phenotype of the mutants,
histological examination of embryonic lung development in mutant
mice was performed by hemotoxylin and eosin staining lung
sections of mice at 16.5 and 18.5 d.p.c. At 16.5 d.p.c., the terminal
sacs were less dilated in lungs of Ndst1 mutants than those in the
wild type (Fig. 1A,B,E,F). The mesenchyma in 16.5 d.p.c. mutant
lungs was also thicker than that in their wild-type littermates (Fig.
1A,B). At 18.5 d.p.c., mutant lungs exhibited less dilated sacs and
thicker septa compared with wild-type lungs (Fig. 1C,D,G,H).
Furthermore, BrdU labeling of 16.5 and 18.5 d.p.c. embryos
indicated that mutant lungs had many more proliferative cells than
normal littermates (Fig. 1I-K), consistent with the observation that
mesenchyma and septa were thicker in mutant lungs than in wild-
type lungs.
Expression of NDST genes during lung developmentAlthough NDST1 is essential for lung morphogenesis, it is not the
only NDST protein expressed during lung development. Lung
Journal of Cell Science 122 (8)
samples from Ndst1 mutants and normal littermates were examined
for expression levels of NDST genes by RT-PCR. At 17.5 d.p.c.,
all four NDST isozymes were expressed in normal lungs. In the
Ndst1–/– lung, expressions of Ndst2, Ndst3 and Ndst4 mRNA
transcripts were upregulated (Fig. 1L), suggesting a potential
redundant effect among the NDST enzymes. Because it is
considered to be the less prevalent phenotype in Ndst2 or Ndst3mutant mice (Forsberg et al., 1999; Grobe et al., 2002; Humphries
et al., 1999), NDST1 might be the most important isoform in the
NDST family. The phenotype observed in Ndst1–/– mice might form
as a result of lack of NDST1 function that cannot be compensated
by other members of this enzyme family.
Defective differentiation of lung cells in Ndst1 mutantsNeonatal respiratory distress observed in Ndst1 mutants might be
caused by reduced production of surfactant proteins (Fan et al.,
2000). Immunostaining analyses revealed a striking reduction in
expression of two surfactant proteins, SFTPC and SFTPA in lungs
of Ndst1-knockout mice. At 16.5 d.p.c., staining of SFTPC was
specifically detected in the distal epithelium (Fig. 2C), whereas
staining of SFTPA was detected throughout the epithelium, including
proximal and distal parts, in lungs of wild-type mice (Fig. 2A).
Significantly, both proteins were barely detectable in mutant lungs
(Fig. 2B,D). Furthermore, analysis of the mutant lungs at 18.5 d.p.c.
revealed a notable decrease of SFTPC-positive cells (Fig. 2E-G).
In parallel, real-time RT-PCR assay indicated that mRNA levels of
Sftpc, Sftpa and Sftpb were significantly reduced in mutant lung at
17.5 d.p.c. (Fig. 2Y). These observations imply that inactivation of
Ndst1 leads to defective development of distal epithelium and
immaturity of type II alveolar cells, which fail to produce surfactant
proteins.
Type I alveolar cells were also found to be immature in Ndst1-
null mice. From 17.5 d.p.c., type I alveolar cells arise from their
Fig. 1. Lung phenotype of Ndst1–/–
mice. (A-H) Histological analysis oflung morphogenesis in mutant mice.(A,C,E,G) Hematoxylin and eosin-stained sections through wild-typelungs at 16.5 d.p.c. (A,E) and 18.5d.p.c. (C,G). (B,D,F,H,J) sectionsthrough Ndst1–/– lungs at 16.5 d.p.c.(B,F) and 18.5 d.p.c. (D,H).(A-D) Low-magnification image oflung cells. (E-H) High-magnificationimage of lung cells. Arrowheads in Gindicate the thin alveoli septa in wild-type lungs; the septa are thick inmutant lungs (indicated by arrowheadsin H). (I-K) Increased lung cellproliferation in Ndst1–/– mice.Proliferating lung cells in 16.5 d.p.c.mice were labeled with BrdU anddetected by antibody staining (I,J).BrdU-positive nuclei are stainedblack. Ndst–/– mice (J) have manymore proliferating lung cells than thewild type (I). (K) BrdU incorporationcalculated as the percentage of cellsstained by BrdU in each field of visionfrom the lungs at 16.5 d.p.c. and 18.5d.p.c. (P<0.01). Bars represent means+ s.d. (L) RT-PCR analysis of NDSTgenes in WT and mutant (–/–) lungs at17.5 d.p.c. Scale bars: 50μm (E-H),100μm (A-D,I,J).
Jour
nal o
f Cel
l Sci
ence
1147NDST1 regulates BMP signaling
precursor cells. Both cell types characteristically express aquaporin-
5 (AQP5), a water channel protein (Krane et al., 1999; Kreda et
al., 2001). Immunofluorescent examination of 16.5 and 18.5 d.p.c.
mutant mouse lungs indicated that the number of AQP5-positive
cells was significantly reduced in Ndst1-null mice (Fig. 2H-L).
Consistently, the mRNA level of Aqp5 was also reduced in lungs
of 17.5 d.p.c. mutant animals (Fig. 2Y).
The expression pattern of the proximal bronchiole epithelium
marker CC10 (UTER/Clara Cell 10 protein), did not alter between
Ndst1 mutant and control lungs (Fig. 2M,N). Immunofluorescent
examination revealed that the number of CC10-immunoreactive
cells did not change in mutant lungs (Fig. 2O-Q). However, the
bronchioles lining with these cells were less dilated in mutant lungs
than in normal littermates (Fig. 2O,P), suggesting that development
of proximal bronchiole epithelium was affected by Ndst1inactivation.
There is a close relationship between blood vessel and lung
structural development. Immunofluorescent examination showed
that the mutant lungs had no significant alteration in distributions
of caveolin-1 (CAV1) and α-smooth muscle actin (SMA), which
are molecular markers of blood vessels (Fig. 2R-V for caveolin-1;
Fig. 2W,X for SMA). It appears that inactivation of Ndst1 does not
affect the lung blood vessel development.
BMP signaling pathway is upregulated in Ndst1–/– lungsThe embryonic lung in Grem1–/– mice exhibits an abnormal
‘proximalized’ phenotype, which is caused by BMP-signaling
dysregulation (Michos et al., 2004). Thus, BMP signaling was
examined in Ndst1–/– lungs. Binding of BMPs to preformed
heteromeric receptor complexes results in the phosphorylation of
Smad proteins, and subsequent stimulation of expression of Id1(Hollnagel et al., 1999; Nohe et al., 2002), Dlx5 (Holleville et al.,
2003; Miyama et al., 1999) and Tbx1 (Bachiller et al., 2003).
Phosphorylated Smad1 (Smad1-P) was highly upregulated in lungs
of 16.5 d.p.c. mutant mice (Fig. 3A,B), and upregulation of ID1
protein was evident at 18.5 d.p.c. (Fig. 3E,F). Interestingly,
overexpressed ID1 in mutant lungs seemed to localize not only in
the nucleus, but also in the cytoplasm. A similar phenomenon was
Fig. 2. Defective differentiation of lung cells in Ndst1–/– mice. Sections of wild-type (A,C,E,H,J,M,O,R,T,W) and Ndst1 mutant lungs (B,D,F,I,K,N,P,S,U,X) wereimmunostained with antibodies as indicated. Nuclei are stained with hematoxylin (A,B) or DAPI (C-F,H-K,O,P,R-U,W,X). The percentage of cells that stained withantibodies against SFTPC (G), AQP5 (L), CC10 (Q) and caveolin-1(V) were calculated from six sections from three lungs of each genotype at 16.5 d.p.c. and 18.5d.p.c. (C-F) Labeling with antibodies against SFTPC indicates that there are fewer type II alveolar cells (red) in mutant lungs than in the wild type. (H-K) AQP5staining reveals there are fewer type I alveolar cells or their precursor cells in mutant lungs than in the wild type. (M-P) Bronchioles in wild-type, as well as in mutantmice, are lined with CC10-immunoreactive Clara cells (brown in M,N; green in O,P). However, the bronchioles are smaller and less dilated in mutant lungs (P) than innormal littermates (O). (R-X) Caveolin-1 and SMA staining suggests that blood vessel structure is unchanged in Ndst1 mutant lungs. (Y) Real-time quantification ofRNA transcripts of genes including Sftpa, Sftpb, Sftpc and Aqp5. **P<0.01. Bars represent means + s.d. Scale bars: 50μm (C-F,H-K,O,P,R-U,W,X), 100μm (A,B),200μm (M,N).
Jour
nal o
f Cel
l Sci
ence
1148
observed in small cell lung cancer with upregulated ID1, although
the reason for this was not clear (Kamalian et al., 2008). mRNA
levels of both Dlx5 and Tbx1 were also increased in lungs of Ndst1-
deficient animals (Fig. 3I). All these data demonstrate that the BMP-
signaling pathway is upregulated in Ndst1–/– lungs. However,
mRNA levels of Bmp2, Bmp4, Bmp5 and Bmp7 were not changed
in Ndst1 mutant lungs (Fig. 3J), indicating that the upregulation of
BMP signaling in the mutants was not caused by an increased BMPs.
Blockade of BMP signaling rescues the defectivedifferentiation of type I and type II cells in Ndst1-null miceTo determine whether dysregulated BMP signaling caused the
defective differentiation of type I and type II cells in Ndst1-null
lungs, Noggin, a BMP antagonist, was applied to block BMP
signaling. Similarly to wild-type lung explants (Fig. 4A-H),
treatment of 15.5 d.p.c. Ndst1–/– lungs with noggin resulted in
significantly downregulated expression of Smad1-P protein (Fig.
4K,L), and upregulation of SFTPC (Fig. 4M,N) and AQP5 (Fig.
4O,P). Furthermore, BrdU labeling indicated that cell proliferation
was decreased in the presence of noggin (Fig. 4I,J). These results
demonstrate that block of BMP signaling could rescue the
developmental failure in type I and type II cells, or their precursor
cells, in mutant lungs. And it reinforced the idea that upregulation
of BMP signaling contributes to the defective lung development in
Ndst1 mutants. However, exogenous noggin inhibited the
proliferation of both wild-type and mutant lungs (Fig. 4R), indicating
that a physiological concentration of BMP is essential for cellular
processes, including DNA synthesis and mitosis.
Decreased binding of BMP2 and BMP4 to endogenous HS inNdst1 mutant lungs Since NDST1 catalyzes the first modification step in biosynthesis
of HS and the HS structure in most basement membrane is affected
in Ndst1–/– mice, the HS chain in mutant lungs is therefore probably
affected. Thus, endogenous HS in wild-type and mutant lungs was
Journal of Cell Science 122 (8)
detected using an antibody that reacts with O-sulfated N-acetylated
glucosamine residues of HSPGs (Fig. 5A-D). Wild-type lungs
showed a strong signal, whereas no signal was detected in mutant
lungs. This demonstrates that loss of NDST1 causes failure in the
synthesis of normal HS chains, which is consistent with a previous
report in the Ndst-1–/– lens (Pan et al., 2006). BMPs are reportedly
involved in lung morphogenesis, and bind to heparin. To investigate
how the BMP-signaling pathway is regulated in Ndst1 mutant lungs,
histochemical assays were performed to test the interaction between
secreted proteins and endogenous HS in mutant lungs. At 18.5 d.p.c.,
the binding of BMP2 and BMP4 was less in mutant lungs than that
in normal littermates (Fig. 5E-H), suggesting that the capacity of
the secreted BMP proteins to bind to HS was decreased in Ndst1–/–
lungs. Pre-treatment of lung sections with heparitinase greatly
reduced the binding in Ndst1-null mice and wild-type littermates
(Fig. 5I,J), indicating that the binding of these secreted proteins is
indeed HS dependent.
HS-dependent binding of BMP to cell surface is essential forBMP internalization in lung cellsBased on our data and previous reports (Ruppert et al., 1996; Fisher
et al., 2006; Jiao et al., 2007), HS seems to have an inhibitory role
in the BMP-signaling pathway. Thus HS-dependent BMP binding
appears to be distinct from receptor-dependent BMP binding. To
study the function of HS-dependent BMP binding to the cell surface,
BMP internalization was monitored in lung epithelial cells. In
cultured wild-type lung epithelial cells, heparitinase treatment
significantly reduced BMP binding to the cell surface and its
consequent internalization (Fig. 6A,C,M,O,U). This demonstrates
that HS-dependent binding of BMP is essential for BMP
internalization.
To test whether BMP receptors are involved in BMP
internalization, noggin, which inhibits BMP signaling by binding
to BMPs and preventing their interaction with receptors (Smith and
Harland, 1992; Zimmerman et al., 1996), was applied to
Fig. 3. BMP-signaling pathway is upregulated in Ndst1–/– lungs.(A-H) Sections of wild-type (A,C,E,G) and Ndst1 mutant lungs(B,D,F,H) immunostained with antibodies as indicated. Controlsections (C,D,G,H) were stained with blocked serum instead ofantibodies. Nuclei are stained with DAPI. (A,B) Labeling withantibodies against Smad1-P (red) reveals the expression level ofSmad1-P is upregulated in mutant lungs. (E-F) Labeling withantibodies against Id1 (red) displays an upregulation ofexpression level of Id1. Scale bar: 100μm. (I) Real-timequantification of RNA transcripts of genes Dlx5 and Tbx1 inlungs from 17.5 d.p.c. mice. **P<0.01. Bars represent means +s.d. (J) Gene expression assayed by RT-PCR of total RNA ofwild-type and mutant lungs at E17.5. β-actin is used as areference for quantification.
Jour
nal o
f Cel
l Sci
ence
1149NDST1 regulates BMP signaling
internalization assays. BMP2 binding to the cell
surface and internalization in normal and Ndst1mutant lung epithelium were not changed in the
presence of noggin (Fig. 6E,G). It is conceivable that
BMP internalization occurs mainly via binding to HS
chains rather than binding to BMP receptors. In
Ndst1–/– lung cells, the binding of BMPs and
consequent internalization was also markedly
attenuated (Fig. 6B,D,F,H,U), indicating the necessity
of NDST1-dependent HS modification during this
process. Similar results were obtained with
mesenchymal cells (Fig. 6Q-T).
It was unexpected that exogenous heparin could
largely rescue BMP2 binding to the cell surface and
consequent internalization in Ndst1–/– mice (Fig.
6J,L,U), whereas its effect on wild-type cells was
much less significant (Fig. 6I,K,U). It seems that not
only cell surface HS, but also extracellular HS,
participates in the internalization of BMP.
Exogenous heparin could also rescue thephenotype of Ndst1–/– lung Since exogenous heparin could rescue the BMP
binding and internalization, it might be also able to
rescue the dysregulated BMP signalling and
consequent morphogenetic defects in Ndst1–/– lungs.
Treatment of 15.5 d.p.c. wild-type and Ndst1–/– lung
explants with 10 μg/ml exogenous heparin, which has
a higher content of N-sulfation than HS, reduced the
expression of Smad1-P (Fig. 7A,B,G,H) and enhanced
the expression of SFTPC and AQP5 (Fig. 7C-F,I-L).
The findings confirm that impaired BMP signaling
with N-sulfation or heparin can facilitate the
differentiation of type I and type II alveolar cells.
Consistently, in wild-type lungs, BMP4 and heparin
together led to the decreased expression of Smad1-P(Fig. 7M,N) and increased expression of SFTPC,
compared with that in lungs treated with BMP4 alone
(red in Fig. 7O,P), but did not affect the expression
of caveolin-1 (Fig. 7O,P, green).
Western blot assays were also performed. Similarly
to results of the histochemical assays, Ndst1–/– lung
explants displayed a much higher level of
phosphorylation of Smad1 than wild-type lung
explants, whereas treatment with noggin or heparin
dramatically reduced this abnormal high level (Fig.
7Q). This confirmed the inhibitory function of heparin
in BMP signaling.
DiscussionNDSTs might compensate for each other in knockout miceHere, we found that loss of Ndst1 in lung results in defective BMP
signaling even with the redundantly enhanced expression of Ndst2,
Ndst3 and Ndst4, whereas FGF signalling, but not hedgehog
signalling, was also affected in mutant lungs (supplementary
material Figs S1 and S2). Ndst1-null mice display severe brain and
facial defects, which might be consistent with impaired sonic
hedgehog (Shh) and FGF interaction with mutant HS (Grobe et al.,
2005) in some mutants. It is also possible that only part of NDST1’s
function could be compensated by other NDST isozymes in lung
development. For instance, it is possible that the hedgehog signaling
in lung was compensated. Although multiple abnormalities
previously described in Ndst1–/– mice were not observed in Ndst2or Ndst3 mutant mice, it is likely that other isoforms of the NDST
enzyme family might have compensated for the loss of Ndst2 or
Ndst3. Considering that NDST1 modulates FGF signaling, but not
BMP and Wnt during lens development (Abramsson et al., 2007;
Pan et al., 2006), compensation between NDSTs seemed to be tissue
dependent. Moreover, in lungs, we found that blood vessel formation
was not affected by loss of NDST1 whereas differentiation of lung
epithelium cells was. This implies that the compensation might even
be cell-type dependent.
Fig. 4. Block of BMPR signaling rescues the defective differentiation of type I and type IIepithelial cells in Ndst1 mutant lungs. Lung explants of 15.5 d.p.c. wild-type (A-H) andNdst1–/– (I-P) mice embryos were cultured for 3 days with control medium (A,C,E,G,I,K,M,O)or medium supplemented with noggin (B,D,F,H,J,L,N,P). (A,B,I,J) BrdU labeling indicatesdecreased lung cell proliferation after treatment with noggin. (C,D,K,L) Smad1-P in lungs issignificantly downregulated after treatment with noggin. (E-H,M-P) SFTPC (red in E,F,M,N)and AQP5 (red in G,H,O,P) in lungs are upregulated after treatment with noggin. Nuclei arestained with DAPI. Scale bar: 50μm. (R) BrdU incorporation calculated as the percentage ofcells stained by BrdU in each field of vision from the lungs in A, B, I and J. Error barsrepresent s.d.
Jour
nal o
f Cel
l Sci
ence
1150
NDST1-dependent modification is essential for HS modulationof the BMP-signaling pathway and BMP internalizationHere, we propose that dysregulation of BMP signaling pathway
contributes to the defective morphogenesis in Ndst1-null lung.
Consistently, similar abnormal septation of the lung airway
epithelium was observed in embryonic lung when GREM1, an
antagonist of BMP, was deficient (Michos et al., 2004). By contrast,
overexpression of BMP4 in embryonic distal lung epithelium
results in thicker mesenchyma than observed in control and in the
‘emphysematous’ phenotype (Bellusci et al., 1996). Nog–/– mice
exhibit abnormal morphology with a malformed and truncated lobe
(Weaver et al., 2003). There are several possible explanations for
these discrepancies. First, endogenous GREM1 is expressed in
proximal airway epithelium (Weaver et al., 1999), whereas noggin
is normally expressed in the distal mesenchyme (Lu et al., 2001).
By inhibition of BMP signaling, GREM1 and noggin might have
different roles in spatial and temporal regulation of lung
development. Thus, the phenotypes observed in these mice models
result from deficiencies in partial epithelium or mesenchyme
Journal of Cell Science 122 (8)
differentiation alone. Similarly, ectopic expression of BMP4 in distal
epithelium had no obvious affect on the epithelium in the proximal
airway (Bellusci et al., 1996). HS plays an upstream regulatory role
in the BMP-signaling pathway, and thereby modulates the
differentiation of all the epithelium and mesenchyme. To determine
how HS does this, further conditional gene knockout studies are
needed. In addition, depending on concentration, BMP promotes
mesenchyme proliferation or death (Bellusci et al., 1996). In Bmp4transgenic mice, a high level of BMP4 resulted in cell death and
inhibition of cell proliferation. However, in our model and in
GREM1-deficient mice, cell proliferation increased, probably
because of the occurrence of endogenous BMP at proper
concentrations. Finally, HS modulates not only BMP signaling, but
also other important pathways during lung development, including
the FGF-signaling pathway (supplementary material Fig. S1). Thus,
the phenotype we report here might result from dysregulation of
several signaling pathways.
Accordingly, we asked how NDST1-dependent HS was involved
in the BMP-signaling pathway. It is reported that HS binds to the
N-terminal of BMP-2 and modulates the function of BMP2 in chick
limb bud assays (Ruppert et al., 1996). In C2C12 myoblast cells,
blockade of cell surface HSPG sulfation or removal of the GAG
chain enhanced BMP2 signaling and bioactivity, which could be
attenuated by exogenous heparin (Jiao et al., 2007). In this study,
we further proved that the binding of HS to BMP inhibits BMP
signalling, rather than facilitates it, in lung development. In
particular, NDST1-dependent modification is essential for the
activity of HS in the regulation of BMP-signaling pathways. In
addition to regulating BMP binding, HS also has a role in binding
noggin to the cell surface. Therefore, reduced noggin binding in
Ndst1 mutant lungs might also contribute to the hyperactivity of
the BMP-signaling pathway (Viviano et al., 2004).
Recent studies have implied that cell surface HSPGs are also
involved in cellular internalization of proteins (Belting, 2003; Jiao
et al., 2007; Payne et al., 2007). Live-cell imaging indicates that
HSPGs mediate cationic ligand internalization via a clathrin- and
caveolin-independent, but flotillin- and dynamin-dependent pathway
(Payne et al., 2007). Our data further demonstrate that the NDST1-
dependent HS modifications, including N-deacetylation and N-
sulfation, are required for BMP internalization. We also observed
that HS-mediated BMP internalization might be independent of
BMP receptors (Fig. 6C,G). More interestingly, we found that
exogenous heparin could partly rescue the BMP internalization
defects caused by loss of NDST1 (Fig. 6J,L). This implies that, not
only cell-surface HS, but also extracellular heparin or HS, also
contribute to BMP internalization, which has not been reported
before.
Taken together, it is postulated that BMPs that bind to HS prefer
to internalise, whereas BMPs that bind to receptors prefer to activate
downstream signaling. The balance between BMP binding to HS
and to receptors might control BMP signaling.
Compared with our previous work on Ndst1 mutant bone (Hu et
al., 2007), the activity of HS in modulating signaling pathways
seems variable in different tissues. First, unlike in embryonic lung,
exogenous heparin might not be able to rescue the morphogenetic
defects in Ndst1–/– embryonic limb bone. Second, FGF1 binding to
the cell surface is attenuated in mutant lung but not in mutant bone.
It is conceivable that other factors participate in the process of HS
binding to cytokines.
In summary, previous studies on the Ndst1-knockout mouse
indicate that HS could regulate various secreted ligands in different
Fig. 5. Reduced binding capacity of BMP2 and BMP4 to endogenous HS inNdst1 mutant lungs. (A-D) Sections of wild-type (A) and Ndst1 mutant lungs (B)were immunostained with antibody HepSS-1. Control sections (C,D) werestained with blocked serum instead of antibody. (E-J) In situ HS binding assaysfor lung sections from 18.5 d.p.c. mice reveal that binding ability of BMP2 andBMP4 to HS is decreased in Ndst1–/– mice (F,H) compared with that of normallittermates (E,G). (I,J) BMP2 binding following pretreatment with heparitinase.Scale bars: 100μm.
Jour
nal o
f Cel
l Sci
ence
1151NDST1 regulates BMP signaling
tissue contexts. Therefore, the tissue-specific regulation of HS and
secreted ligands might contribute to the observation that HS plays
a vital role in different developmental tissues via various signaling
pathways. In this study, we provide a mouse model for exploring
the function of HS in BMP signaling. We point out the different
roles of HS in regulating BMP signaling and BMP internalization,
and thus present an explanation for the mechanistic involvement
of NDST1-dependent HS in modulation of the BMP-signaling
pathway during lung development,
In addition to insights into developmental regulation, our study
also has important clinical implications. We found an inhibitory
effect of heparin on the modulation of BMP signalling, which might
provide an explanation for the clinical observations that heparin
can improve outcome in small-cell lung cancer (SCLC) (Altinbas
et al., 2004; Lebeau et al., 1994), in which BMP8 is overexpressed
(Henderson et al., 2005).
Materials and MethodsMiceThe generation of the Ndst1-deficient mice and molecular examination by PCR todistinguish wild-type and mutant Ndst1 alleles have been reported previously (Fanet al., 2000). All mice used in this study were bred and maintained at Shanghai Instituteof Biological Sciences under specific pathogen-free conditions in accordance withinstitutional guidelines.
Histological and immunohistochemical analysisEmbryonic lungs were fixed overnight in 4% buffered formaldehyde at 4°C andembedded in paraffin for sectioning. For histological analysis, 5 μm sections were
Fig. 6. NDST1-dependent HS binds BMP2 and mediates BMP2 internalization. (A-T) Epithelial cells (A-P) or mesenchymal cells (Q-T) were untreated (control) orpretreated with: noggin for 1 hour, heparin for 1 hour, or heparitinase for 4 hours. The cells were incubated with BMP2 pre-labeled with goat anti-BMP2 (30 minutes,4°C) and then fixed to detect surface-bound BMP2 (A,B,E,F,I,J,M,N,Q,R) or transferred to 37°C for 1 hour (C,D,G,H,K,L,O,P,S,T) to allow BMP2 internalization.BMP2 was detected with FITC-conjugated anti-goat IgG (green), and cell nuclei were stained with DAPI. Scale bar: 25μm. (U) Relative fluorescent signaling of eachcell from A-P was quantified using confocal software from Leica microsystems. Results are means + s.d.
Jour
nal o
f Cel
l Sci
ence
1152 Journal of Cell Science 122 (8)
stained with hematoxylin and eosin, mounted in xylene-based medium and
photographed. For immunohistochemistry, 5 μm tissue sections were pretreated with
10 mM sodium citrate buffer (pH 6.0) at 95°C, and then incubated overnight at 4°C
with anti-CC10 (T-18), anti-SFTPA (N-19), anti-SFTPC (M-20), anti-AQP5 (G-19),
anti-caveolin-1 (N-20), anti-Smad1-P (Ser463-Ser465), anti-Id1 (C-20), anti-Patched
(G-19), anti-Gli1 (N-16) (all from Santa Cruz Biotechnology, Santa Cruz, CA), anti-
SMA (Sigma, St Louis, MO) or anti-HepSS-1 (Seikagaku Corp., Tokyo, Japan). For
enzymatic staining, biotinylated secondary antibodies and the ABC staining system
(Santa Cruz) were applied. The images were captured on a cooled CCD camera (SPOT
II, Diagnostic Instruments, Sterling Heights, MI) on an Olympus BX51 microscope.
For immunofluorescence, secondary antibodies conjugated with appropriate
fluorochrome, FITC, Cy3, Cy5 (Jackson ImmunoResearch, West Grove, PA), were
used. Digital images were analyses by confocal laser-scanning microscope (Leica
SP2 system) and processed using Adobe Photoshop. At least three embryos for each
genotype were analyzed for each antibody.
RT-PCRTotal RNA was isolated from lungs of 17.5 d.p.c. Ndst1–/– and wild-type embryos
using Trizol Reagent (Invitrogen, Paisley, UK), and then reverse transcribed with
Super-scriptase (Invitrogen). The primers used in PCR assays were Ndst1 (forward,
5�-CTG CCC TGG CGT GCC TCC-3�; reverse, 5�-TGG GCC GTG TCA CAT AGA
GCA GT-3�); Ndst3 (forward, 5�-TCA CAT GCA GCC CCA CCT CTT-3�; reverse,
5�-GCT CCC CTC CAT GAA TAC TCT TGT-3�); Ndst2, Ndst4 (Pan et al., 2006);
Bmp2 (forward, 5�-TCT TCC GGG AAC AGA TAC AGG-3�; reverse, 5�-TCT CCT
CTA AAT GGG CCA CTT-3�); Bmp4 (Zhang et al., 2007), β-actin (Actb) (forward,
5�-CTG GCT GGC CGG GAC CTG ACA-3�; reverse, 5�-ACC GCT CGT TGC
CAA TAG TGA TGA-3�). Actb was used as an internal control for quantification.
Real-time PCR assays were performed on a DNA Engine Opticon 2 (MJ Research,
Watertown, MA) using the DyNAmo SYBR Green qPCR kit (FinnzymesOy, Espoo,
Finland). The data were expressed as relative mRNA (gene) copies, which were
normalized to the expression level of Actb. The following primers were used: Aqp5(forward, 5�-AGC CTT ATC CAT TGG CTT GTC-3�; reverse, 5�-TGA GAG GGG
CTG AAC CGA T-3�); SftpA (Okubo and Hogan, 2004); SftpB (forward, 5�-ACG
TCC TCT GGA AGC CTT CA-3�; reverse, 5�-TGT CTT CTT GGA GCC ACA
ACA G-3�); SftpC (forward, 5�-ACC CTG TGT GGA GAG CTA CCA-3�; reverse,
5�-TTT GCG GAG GGT CTT TCC T-3�); Dlx5 (forward, 5�-GTC CCA AGC ATC
CGA TCC G-3�; reverse, 5�-GCT TTG CCA TAA GAA GCA GAG G-3�); Tbx1(forward, 5�-AGG CAG ACG AAT GTT CCC C-3�; reverse, 5�-GCT TGT CAT
CTA CGG GCA CA-3�).
BrdU labeling and detectionMouse embryos were labeled with BrdU (BrdU labeling and detection kit II, Roche,
Germany) by intraperitoneal injection of 10 mM BrdU (1-2 ml per 100 g body weight)
into pregnant females 1 hour before sacrifice. Cultured lung explants were treated
with 100 μM BrdU for 1.5 hours before harvesting, and then were fixed in 95%
ethanol at 4°C and embedded in paraffin. Antibody staining of embryo sections was
carried out according to the manufacturer’s instructions. The number of BrdU-positive
nuclei and total cells in each field of vision was estimated from eight sections from
three animals for each genotype.
In situ HS-binding assaysThe assays were performed on paraffin-embedded sections essentially as previously
described for cryosections (Chang et al., 2000; Friedl et al., 1997). Briefly, after
blocking, sections were incubated with 15 nM BMP2, 15 nM BMP4 and 30 nM
FGF1 (all from R&D Systems, Wiesbaden, Germany), respectively. Then, sections
were incubated with anti-BMP2, anti-BMP4, anti-FGF1 antibodies (all from R&D
Systems) and stained using the ABC staining system (Santa Cruz).
Organ culture of embryonic lung explantsMouse embryonic lungs were cultured essentially as previously described (Dean et
al., 2005; del Moral et al., 2006). Briefly, lungs were isolated from 15.5 d.p.c. crosses
of Ndst1+/– mice. They were placed in a six-well plate on an 8 μm Nucleopore
membrane floating in 1 ml BGJ-B medium (GibcoBRL, Grand Island, NY) with
antibiotic/antimycotic (Life Technologies, Paisley, UK) and 0.1% BSA, and were
maintained at 37°C in a humidified 5% CO2 incubator. Lung explants were cultured
in medium supplemented with 10 μg/ml heparin (Sigma) or with 500 ng/ml noggin
(R&D Systems) for 3 days and were compared with explants cultured in BGJ-B
medium. The medium was changed every day.
Primary lung epithelial and mesenchymal cell culturesEpithelial and mesenchymal cell cultures were obtained by differential adhesion as
previously described (Lebeche et al., 1999). Briefly, whole lungs were dissected at
15.5 d.p.c. and digested with 0.4% dispase 0.8% Collagenase (37°C, 60 minutes;
GibcoBRL) to give rise to single cells. The resulting filtered suspension was plated
in 30 mm dishes and incubated at 37°C in a humidified 5% CO2 incubator for 1 hour
for differential adhesion. The supernatant containing epithelium cells was removed
and centrifuged at 1000 r.p.m. for 10 minutes at room temperature. The cell pellet
was resuspended in Dulbecco’s modified Eagle’s medium (DMEM) with 10% heat-
inactivated fetal bovine serum, and plated in dishes. The mesenchymal cells attached
to the dish were washed with PBS and cultured with fresh medium.
Fig. 7. Exogenous heparin negatively regulates BMP signaling in lung explants. Lung explants of 15.5 d.p.c. wild-type (A-F, Q-T) and Ndst1–/– (G-L) mice embryoswere cultured for 3 days with control medium (A,C,E,G,I,K) or medium supplemented with heparin (B,D,F,H,J,L), BMP4 (M,O) or simultaneously with BMP4 andheparin (N,P). The expression levels of protein Smad1-P (red in A,B,G,H) in lungs are downregulated in the presence of heparin. The expression levels of proteinSFTPC (red in C,D,I,J) and AQP5 (red in E,F,K,L) in lungs are upregulated in the presence of heparin. Smad phosphorylation in response to BMP4 (red in M) isdownregulated after treatment with heparin (red in N). Expression of SFTPC was upregulated in presence of both heparin and BMP4 (red in O) compared with BMP4alone (red in P). However, expression of caveolin-1 remains unchanged (green in O,P). Nuclei are stained with DAPI. Scale bar: 50μm. (Q) Lung explants were treatedwith noggin and heparin for 3 days and then collected for western blot. Samples were immunoblotted with indicated antibodies; β-actin was used as an internal control.
Jour
nal o
f Cel
l Sci
ence
1153NDST1 regulates BMP signaling
BMP internalization assaysBMP2 internalization was performed mostly as previously described (Jiao et al., 2007).Briefly, BMP2 (12 μl of 400 ng/ml; R&D systems) was incubated with goat anti-BMP2 antibody (40 μl of 500 ng/ml; Santa Cruz) for 30 minutes at 37°C to formthe BMP2-anti-BMP2 complex. Lung epithelial or mesenchymal cells, seeded onglass coverslips in 24-well plates, were incubated with BMP2-anti-BMP2 complexat 4°C for 30 minutes. After a wash with ice-cold serum-free DMEM, the cells wereincubated at 37°C for 30 minutes. Cells were then incubated with FITC-conjugatedsecondary antibody (Jackson ImmunoResearch) and 4,6-diamidino-2-phenylindole(DAPI) and examined by confocal laser-scanning microscope (Leica SP2 system)after being fixed.
Western blotLung explants were homogenized and lysed after treated with noggin and heparin.Then lysates were collected after brief concentration. Immunoblotting was performedas described previously (Huang et al., 2002) with primary antibodies against Smad1-P (Cell Signaling Technology), Smad1 (a kind gift from Yeguang Chen, TsinghuaUniversity, Beijing, China) and β-actin (Sigma).
Statistical analysisThe Student’s t-test was used to determine levels of difference between groups, andP values for significance were set to 0.05. Values for all measurements were expressedas the means ± s.d.
We are grateful to Xinhua Lin and Xiaoyan Ding for helpfuldiscussions and Yeguang Chen for supplying antibody against Smad1.This work was supported by Minster for Science and Technology GrantG1998051007 and Chinese High-Tech R&D Program (863)-2001AA231011 and 0022Z2002.
ReferencesAbramsson, A., Kurup, S., Busse, M., Yamada, S., Lindblom, P., Schallmeiner, E.,
Stenzel, D., Sauvaget, D., Ledin, J., Ringvall, M. et al. (2007). Defective N-sulfation
of heparan sulfate proteoglycans limits PDGF-BB binding and pericyte recruitment in
vascular development. Genes Dev. 21, 316-331.
Aikawa, J. and Esko, J. D. (1999). Molecular cloning and expression of a third member
of the heparan sulfate/heparin GlcNAc N-deacetylase/ N-sulfotransferase family. J. Biol.Chem. 274, 2690-2695.
Aikawa, J., Grobe, K., Tsujimoto, M. and Esko, J. D. (2001). Multiple isozymes of
heparan sulfate/heparin GlcNAc N-deacetylase/GlcN N-sulfotransferase: structure and
activity of the fourth member, NDST4. J. Biol. Chem. 276, 5876-5882.
Altinbas, M., Coskun, H. S., Er, O., Ozkan, M., Eser, B., Unal, A., Cetin, M. and
Soyuer, S. (2004). A randomized clinical trial of combination chemotherapy with and
without low-molecular-weight heparin in small cell lung cancer. J. Thromb. Haemost.2, 1266-1271.
Bachiller, D., Klingensmith, J., Shneyder, N., Tran, U., Anderson, R., Rossant, J. and
De Robertis, E. M. (2003). The role of chordin/Bmp signals in mammalian pharyngeal
development and DiGeorge syndrome. Development 130, 3567-3578.
Bellusci, S., Henderson, R., Winnier, G., Oikawa, T. and Hogan, B. L. (1996). Evidence
from normal expression and targeted misexpression that bone morphogenetic protein
(Bmp-4) plays a role in mouse embryonic lung morphogenesis. Development 122, 1693-
1702.
Bellusci, S., Furuta, Y., Rush, M. G., Henderson, R., Winnier, G. and Hogan, B. L.
(1997). Involvement of Sonic hedgehog (Shh) in mouse embryonic lung growth and
morphogenesis. Development 124, 53-63.
Belting, M. (2003). Heparan sulfate proteoglycan as a plasma membrane carrier. TrendsBiochem. Sci. 28, 145-151.
Chang, Z., Meyer, K., Rapraeger, A. C. and Friedl, A. (2000). Differential ability of
heparan sulfate proteoglycans to assemble the fibroblast growth factor receptor complex
in situ. FASEB J. 14, 137-144.
Dean, C. H., Miller, L. A., Smith, A. N., Dufort, D., Lang, R. A. and Niswander, L. A.
(2005). Canonical Wnt signaling negatively regulates branching morphogenesis of the
lung and lacrimal gland. Dev. Biol. 286, 270-286.
del Moral, P. M., De Langhe, S. P., Sala, F. G., Veltmaat, J. M., Tefft, D., Wang, K.,
Warburton, D. and Bellusci, S. (2006). Differential role of FGF9 on epithelium and
mesenchyme in mouse embryonic lung. Dev. Biol. 293, 77-89.
Eblaghie, M. C., Reedy, M., Oliver, T., Mishina, Y. and Hogan, B. L. (2006). Evidence
that autocrine signaling through Bmpr1a regulates the proliferation, survival and
morphogenetic behavior of distal lung epithelial cells. Dev. Biol. 291, 67-82.
Eriksson, I., Sandback, D., Ek, B., Lindahl, U. and Kjellen, L. (1994). cDNA cloning
and sequencing of mouse mastocytoma glucosaminyl N-deacetylase/N-sulfotransferase,
an enzyme involved in the biosynthesis of heparin. J. Biol. Chem. 269, 10438-10443.
Esko, J. D. and Selleck, S. B. (2002). Order out of chaos: assembly of ligand binding sites
in heparan sulfate. Annu. Rev. Biochem. 71, 435-471.
Fan, G., Xiao, L., Cheng, L., Wang, X., Sun, B. and Hu, G. (2000). Targeted disruption
of NDST-1 gene leads to pulmonary hypoplasia and neonatal respiratory distress in mice.
FEBS Lett. 467, 7-11.
Fisher, M. C., Li, Y., Seghatoleslami, M. R., Dealy, C. N., Kosher, R. A. (2006). Heparan
sulfate proteoglycans including syndecan-3 modulate BMP activity during limb cartilage
differentiation. Matrix Biol. 25, 27-39.
Ford-Perriss, M., Guimond, S. E., Greferath, U., Kita, M., Grobe, K., Habuchi, H.,
Kimata, K., Esko, J. D., Murphy, M. and Turnbull, J. E. (2002). Variant heparan
sulfates synthesized in developing mouse brain differentially regulate FGF signaling.
Glycobiology 12, 721-727.
Forsberg, E., Pejler, G., Ringvall, M., Lunderius, C., Tomasini-Johansson, B., Kusche-
Gullberg, M., Eriksson, I., Ledin, J., Hellman, L. and Kjellen, L. (1999). Abnormal
mast cells in mice deficient in a heparin-synthesizing enzyme. Nature 400, 773-776.
Friedl, A., Chang, Z., Tierney, A. and Rapraeger, A. C. (1997). Differential binding of
fibroblast growth factor-2 and -7 to basement membrane heparan sulfate: comparison
of normal and abnormal human tissues. Am. J. Pathol. 150, 1443-1455.
Grobe, K., Ledin, J., Ringvall, M., Holmborn, K., Forsberg, E., Esko, J. D. and Kjellen,
L. (2002). Heparan sulfate and development: differential roles of the N-acetylglucosamine
N-deacetylase/N-sulfotransferase isozymes. Biochim. Biophys. Acta 1573, 209-215.
Grobe, K., Inatani, M., Pallerla, S. R., Castagnola, J., Yamaguchi, Y. and Esko, J. D.
(2005). Cerebral hypoplasia and craniofacial defects in mice lacking heparan sulfate
Ndst1 gene function. Development 132, 3777-3786.
Hacker, U., Nybakken, K. and Perrimon, N. (2005). Heparan sulphate proteoglycans:
the sweet side of development. Nat. Rev. Mol. Cell. Biol. 6, 530-541.
Hashimoto, Y., Orellana, A., Gil, G. and Hirschberg, C. B. (1992). Molecular cloning
and expression of rat liver N-heparan sulfate sulfotransferase. J. Biol. Chem. 267, 15744-
15750.
Henderson, L. J., Coe, B. P., Lee, E. H., Girard, L., Gazdar, A. F., Minna, J. D., Lam,
S., MacAulay, C. and Lam, W. L. (2005). Genomic and gene expression profiling of
minute alterations of chromosome arm 1p in small-cell lung carcinoma cells. Br. J. Cancer92, 1553-1560.
Holleville, N., Quilhac, A., Bontoux, M. and Monsoro-Burq, A. H. (2003). BMP signals
regulate Dlx5 during early avian skull development. Dev. Biol. 257, 177-189.
Hollnagel, A., Oehlmann, V., Heymer, J., Ruther, U. and Nordheim, A. (1999). Id genes
are direct targets of bone morphogenetic protein induction in embryonic stem cells. J.Biol. Chem. 274, 19838-19845.
Hu, Z., Yu, M. and Hu, G. (2007). NDST-1 modulates BMPR and PTHrP signaling during
endochondral bone formation in a gene knockout model. Bone 40, 1462-1474.
Huang, R., Wu, T., Xu, L., Liu, A., Ji, Y. and Hu, G. (2002). Upstream binding factor
up-regulated in hepatocellular carcinoma is related to the survival and cisplatin-
sensitivity of cancer cells. FASEB J. 16, 293-301.
Humphries, D. E., Wong, G. W., Friend, D. S., Gurish, M. F., Qiu, W. T., Huang, C.,
Sharpe, A. H. and Stevens, R. L. (1999). Heparin is essential for the storage of specific
granule proteases in mast cells. Nature 400, 769-772.
Jiao, X., Billings, P. C., O’Connell, M. P., Kaplan, F. S., Shore, E. M. and Glaser, D.
L. (2007). Heparan sulfate proteoglycans (HSPGs) modulate BMP2 osteogenic bioactivity
in C2C12 cells. J. Biol. Chem. 282, 1080-1086.
Kamalian, L., Gosney, J. R., Forootan, S. S., Foster, C. S., Bao, Z. Z., Beesley, C. and
Ke, Y. (2008). Increased expression of Id family proteins in small cell lung cancer and
its prognostic significance. Clin. Cancer Res. 14, 2318-2325.
Krane, C. M., Towne, J. E. and Menon, A. G. (1999). Cloning and characterization of
murine Aqp5: evidence for a conserved aquaporin gene cluster. Mamm. Genome 10,
498-505.
Kreda, S. M., Gynn, M. C., Fenstermacher, D. A., Boucher, R. C. and Gabriel, S. E.
(2001). Expression and localization of epithelial aquaporins in the adult human lung.
Am. J. Respir. Cell Mol. Biol. 24, 224-234.
Kusche-Gullberg, M., Eriksson, I., Pikas, D. S. and Kjellen, L. (1998). Identification
and expression in mouse of two heparan sulfate glucosaminyl N-deacetylase/N-
sulfotransferase genes. J. Biol. Chem. 273, 11902-11907.
Lebeau, B., Chastang, C., Brechot, J. M., Capron, F., Dautzenberg, B., Delaisements,
C., Mornet, M., Brun, J., Hurdebourcq, J. P. and Lemarie, E. (1994). Subcutaneous
heparin treatment increases survival in small cell lung cancer: “Petites Cellules” Group.
Cancer 74, 38-45.
Lebeche, D., Malpel, S. and Cardoso, W. V. (1999). Fibroblast growth factor interactions
in the developing lung. Mech. Dev. 86, 125-136.
Lin, X. (2004). Functions of heparan sulfate proteoglycans in cell signaling during
development. Development 131, 6009-6021.
Lindahl, U., Kusche-Gullberg, M. and Kjellen, L. (1998). Regulated diversity of heparan
sulfate. J. Biol. Chem. 273, 24979-24982.
Lu, M. M., Yang, H., Zhang, L., Shu, W., Blair, D. G. and Morrisey, E. E. (2001). The
bone morphogenic protein antagonist gremlin regulates proximal-distal patterning of the
lung. Dev. Dyn. 222, 667-680.
Michos, O., Panman, L., Vintersten, K., Beier, K., Zeller, R. and Zuniga, A. (2004).
Gremlin-mediated BMP antagonism induces the epithelial-mesenchymal feedback
signaling controlling metanephric kidney and limb organogenesis. Development 131,
3401-3410.
Miettinen, P. J., Warburton, D., Bu, D., Zhao, J. S., Berger, J. E., Minoo, P., Koivisto,
T., Allen, L., Dobbs, L., Werb, Z. et al. (1997). Impaired lung branching morphogenesis
in the absence of functional EGF receptor. Dev. Biol. 186, 224-236.
Miyama, K., Yamada, G., Yamamoto, T. S., Takagi, C., Miyado, K., Sakai, M., Ueno,
N. and Shibuya, H. (1999). A BMP-inducible gene, dlx5, regulates osteoblast
differentiation and mesoderm induction. Dev. Biol. 208, 123-133.
Nohe, A., Hassel, S., Ehrlich, M., Neubauer, F., Sebald, W., Henis, Y. I. and Knaus,
P. (2002). The mode of bone morphogenetic protein (BMP) receptor oligomerization
determines different BMP-2 signaling pathways. J. Biol. Chem. 277, 5330-5338.
Okubo, T. and Hogan, B. L. (2004). Hyperactive Wnt signaling changes the developmental
potential of embryonic lung endoderm. J. Biol. 3, 11.
Pan, Y., Woodbury, A., Esko, J. D., Grobe, K. and Zhang, X. (2006). Heparan sulfate
biosynthetic gene Ndst1 is required for FGF signaling in early lens development.
Development 133, 4933-4944.
Jour
nal o
f Cel
l Sci
ence
1154 Journal of Cell Science 122 (8)
Pan, Y., Carbe, C., Powers, A., Zhang, E. E., Esko, J. D., Grobe, K., Feng, G. S. and
Zhang, X. (2008). Bud specific N-sulfation of heparan sulfate regulates Shp2-dependent
FGF signaling during lacrimal gland induction. Development 135, 301-310.
Payne, C. K., Jones, S. A., Chen, C. and Zhuang, X. (2007). Internalization and trafficking
of cell surface proteoglycans and proteoglycan-binding ligands. Traffic 8, 389-401.
Ringvall, M., Ledin, J., Holmborn, K., van Kuppevelt, T., Ellin, F., Eriksson, I.,
Olofsson, A. M., Kjellen, L. and Forsberg, E. (2000). Defective heparan sulfate
biosynthesis and neonatal lethality in mice lacking N-deacetylase/N-sulfotransferase-1.
J. Biol. Chem. 275, 25926-25930.
Ruppert, R., Hoffmann, E. and Sebald, W. (1996). Human bone morphogenetic protein
2 contains a heparin-binding site which modifies its biological activity. Eur. J. Biochem.237, 295-302.
Salmivirta, M., Lidholt, K. and Lindahl, U. (1996). Heparan sulfate: a piece of
information. FASEB J. 10, 1270-1279.
Smith, W. C. and Harland, R. M. (1992). Expression cloning of noggin, a new dorsalizing
factor localized to the Spemann organizer in Xenopus embryos. Cell 70, 829-840.
Viviano, B. L., Paine-Saunders, S., Gasiunas, N., Gallagher, J. and Saunders, S. (2004).
Domain-specific modification of heparan sulfate by Qsulf1 modulates the binding of
the bone morphogenetic protein antagonist Noggin. J. Biol. Chem. 279, 5604-5611.
Warburton, D., Schwarz, M., Tefft, D., Flores-Delgado, G., Anderson, K. D. and
Cardoso, W. V. (2000). The molecular basis of lung morphogenesis. Mech Dev 92, 55-
81.
Weaver, M., Yingling, J. M., Dunn, N. R., Bellusci, S. and Hogan, B. L. (1999). Bmp
signaling regulates proximal-distal differentiation of endoderm in mouse lung
development. Development 126, 4005-4015.
Weaver, M., Batts, L. and Hogan, B. L. (2003). Tissue interactions pattern the mesenchyme
of the embryonic mouse lung. Dev. Biol. 258, 169-184.
Weinstein, M., Xu, X., Ohyama, K. and Deng, C. X. (1998). FGFR-3 and FGFR-4 function
cooperatively to direct alveogenesis in the murine lung. Development 125, 3615-3623.
Yabe, T., Hata, T., He, J. and Maeda, N. (2005). Developmental and regional expression
of heparan sulfate sulfotransferase genes in the mouse brain. Glycobiology 15, 982-993.
Zhang, Y., Rath, N., Hannenhalli, S., Wang, Z., Cappola, T., Kimura, S., Atochina-
Vasserman, E., Lu, M. M., Beers, M. F. and Morrisey, E. E. (2007). GATA and Nkx
factors synergistically regulate tissue-specific gene expression and development in vivo.
Development 134, 189-198.
Zimmerman, L. B., De Jesus-Escobar, J. M. and Harland, R. M. (1996). The Spemann
organizer signal noggin binds and inactivates bone morphogenetic protein 4. Cell 86,
599-606.
Jour
nal o
f Cel
l Sci
ence